Current Guidelines for the Management of Aggressive Non-Hodgkin’s Lymphoma

被引:0
作者
Maurizio Martelli
Vitaliana De Sanctis
Giuseppe Avvisati
Franco Mandelli
机构
[1] Università ‘La Sapienza’,Haematology, Department of Human Biopathology
来源
Drugs | 1997年 / 53卷
关键词
Lymphoma; Clin Oncol; Bleomycin; International Prognostic Index; Autologous Bone Marrow Transplantation;
D O I
暂无
中图分类号
学科分类号
摘要
The prognosis of aggressive non-Hodgkin’s lymphoma (NHL) has improved greatly during recent years with the use of combination chemotherapy.
引用
收藏
页码:957 / 972
页数:15
相关论文
共 189 条
[1]  
Weisenburger DD(1994)Epidemiology of non-Hodgkin’s lymphoma: recent findings regarding an emerging epidemic Ann Oncol 5 19-24
[2]  
Lee Harris N(1982)summary and description of a working formulation of clinical usage Cancer 49 2112-35
[3]  
Jaffe ES(1994)A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group Blood 84 1361-92
[4]  
Stein H(1996)Lymphoma classification: the gap between biology and clinical management is closing Blood 88 4085-9
[5]  
Hiddeman W(1993)A predictive model for aggressive NHL: the international non-Hodgkins lymphoma factors project N Engl J Med 329 987-94
[6]  
Longo DL(1971)Report of the committee on Hodgkin’s disease staging classification Cancer Res 31 1860-1
[7]  
Coiffier B(1975)Advanced diffuse histiocytic lymphoma, a potentially curable disease Lancet I 248-50
[8]  
Shipp MA(1985)Diffuse aggressive lymphoma: increased survival after alternating flexible sequences of Pro MACE and MOPP chemotherapy Ann Intern Med 98 304-9
[9]  
Harrington DP(1990)The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen J Clin Oncol 8 84-93
[10]  
Anderson JR(1988)The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma Semin Hematol 25 22-33